Cargando…

Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1

BACKGROUND: Pulmonary hypertension (PH) is a devastating disease characterized by vasoconstriction and vascular remodeling, leading to right ventricular failure and death. PH is a common complication of chronic obstructive pulmonary disease (COPD). Accumulating evidence demonstrate that microRNAs pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhao, Li, Ping, Yuan, Qun, Wang, Xi, Ma, Hong-Hong, Zhuan, Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039540/ https://www.ncbi.nlm.nih.gov/pubmed/36964568 http://dx.doi.org/10.1186/s12931-023-02387-5

Ejemplares similares

LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis
por: Liu, Xiaojing, et al.
Publicado: (2021)

Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression
por: Zheng, Wan, et al.
Publicado: (2023)

Intervening with the Nitric Oxide Pathway to Alleviate Pulmonary Hypertension in Pulmonary Vein Stenosis
por: van Duin, Richard W. B., et al.
Publicado: (2019)

Inhibiting miR-1 attenuates pulmonary arterial hypertension in rats
por: Liu, Yun, et al.
Publicado: (2021)

Nitric oxide synthases in infants and children with pulmonary hypertension and congenital heart disease
por: Hoehn, Thomas, et al.
Publicado: (2009)

Upregulation of nitric oxide synthase in mice with severe hypoxia-induced pulmonary hypertension
por: Fagan, Karen A, et al.
Publicado: (2001)

Role for miR-204 in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

AhR Antagonist Promotes Differentiation of Papillary Thyroid Cancer via Regulating circSH2B3/miR-4640-5P/IGF2BP2 Axis
por: Sa, Ri, et al.
Publicado: (2021)

Inhibition of nitric oxide synthase unmasks vigorous vasoconstriction in established pulmonary arterial hypertension
por: Tanaka, Mariko, et al.
Publicado: (2017)

Nitric oxide and pulmonary hypertension
por: Sim, Ji-Yeon
Publicado: (2010)

Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease
por: Aminuddin, Farzian, et al.
Publicado: (2013)

Role of miR‐21‐5p/FilGAP axis in estradiol alleviating the progression of monocrotaline‐induced pulmonary hypertension
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines
por: Hu, Hong-Ling, et al.
Publicado: (2017)

Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
por: Koo, Hee Sun, et al.
Publicado: (2011)

miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension
por: Russomanno, Giusy, et al.
Publicado: (2020)

Expression of Nitric Oxide Synthase Isoenzyme in Lung Tissue of Smokers with and without Chronic Obstructive Pulmonary Disease
por: Jiang, Wen-Ting, et al.
Publicado: (2015)

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis
por: Sun, Yuanyuan, et al.
Publicado: (2022)

Nitric oxide and pulmonary arterial hypertension
por: Chester, Adrian H., et al.
Publicado: (2017)

Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase
por: Zhu, Mo-Li, et al.
Publicado: (2020)

Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Córdoba-Lanús, Elizabeth, et al.
Publicado: (2023)

Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients
por: Duarte, Julio D., et al.
Publicado: (2018)

Identification of non-small cell lung cancer with chronic obstructive pulmonary disease using clinical symptoms and routine examination: a retrospective study
por: Zhuan, Bing, et al.
Publicado: (2023)

Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a
por: Li, Fangwei, et al.
Publicado: (2021)

Downregulation of miR-98 contributes to hypoxic pulmonary hypertension by targeting ALK1
por: Li, Qingling, et al.
Publicado: (2019)

Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension
por: Perez-Vizcaino, Francisco, et al.
Publicado: (2022)

miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Jing, et al.
Publicado: (2018)

Plasma miR-150-5p as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Ding, Yichuan, et al.
Publicado: (2023)

Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease
por: Ji, Dejiang, et al.
Publicado: (2022)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension
por: Ma, Hong, et al.
Publicado: (2022)

Endotoxin-induced pulmonary hyporesponsiveness to inhaled nitric oxide is improved by nitric oxide synthase 2 inhibition
por: Bopp, C, et al.
Publicado: (2000)

Retracted: Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Neuronal nitric oxide synthase in hypertension – an update
por: Zhang, Yin Hua
Publicado: (2016)

The clinical value of lncRNA MALAT1 and its targets miR‐125b, miR‐133, miR‐146a, and miR‐203 for predicting disease progression in chronic obstructive pulmonary disease patients
por: Liu, Shuang, et al.
Publicado: (2020)

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice
por: Gredic, Marija, et al.
Publicado: (2022)

miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response
por: Scalavino, Viviana, et al.
Publicado: (2020)

The inhibitor miR-21 regulates macrophage polarization in an experimental model of chronic obstructive pulmonary disease
por: Lu, JunJuan, et al.
Publicado: (2021)

Clinical relevance of miR-423-5p levels in chronic obstructive pulmonary disease patients
por: Zhang, Xin, et al.
Publicado: (2022)

Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
por: Tang, Honghu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j39cg8f190gq25mbitsc2g8e26